Homatropine Methylbromide

CAS 80-49-9 3 current records 1 historicalSmall Molecule

Who holds supplier records for Homatropine Methylbromide? 3 organisations hold a current record for Homatropine Methylbromide: an active US FDA Type II Drug Master File or a CEP. A further 1 organisation has only historical (inactive) DMF filings. 1 of them holds a valid EU Certificate of Suitability. Recorded organisation countries for current records: United States (1), China (1) and India (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Homatropine Methylbromide: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/homatropine-methylbromide

Reading the evidence

  • 3 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 1 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (3)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Homatropine Methylbromide. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Homatropine Methylbromide sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (1)

Certificates of Suitability on the EDQM register for Homatropine Methylbromide, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 2 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
C-SQUARED PHARMA LIMITED CorkIE
CEP 2016-248 - Rev 01
Homatropine Methylbromide
Aug 2024—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (1)

Organisations whose Type II DMFs for Homatropine Methylbromide are no longer active. These show a past filing, not current supply.

Show all 1 historical record

Overview

Homatropine Methylbromide is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1200851).

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Homatropine Methylbromide?

3 organisations hold an active US FDA Type II Drug Master File or a CEP for Homatropine Methylbromide: C-SQUARED PHARMA LTD (United States), HUBEI BIOCAUSE HEILEN PHARMACEUTICAL CO LTD (China) and Scl Lifesciences Limited (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Homatropine Methylbromide Drug Master Files are active?

C-SQUARED PHARMA LTD (DMF 31086), HUBEI BIOCAUSE HEILEN PHARMACEUTICAL CO LTD (DMF 28530) and Scl Lifesciences Limited (DMF 23963). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Homatropine Methylbromide records mean?

1 organisation has only inactive Type II DMFs for Homatropine Methylbromide. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Homatropine Methylbromide have a European Certificate of Suitability?

Yes. 1 organisation holds a valid CEP for Homatropine Methylbromide on the EDQM register, including C-SQUARED PHARMA LIMITED Cork (IE). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Homatropine Methylbromide supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Homatropine Methylbromide?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.